Fuse Science Stock

Fuse Science Equity

The The Equity of Fuse Science (DROP) as of Aug 3, 2026 is -11.22 M USD. In the previous year, The Equity was -2.18 M USD — a change of 415.49% (lower).

Equity

-11.22 MUSD

YoY

415.49%

Last updated:

In 2026, Fuse Science's equity was -11.22 M USD, a 415.49% increase from the -2.18 M USD equity in the previous year.

Access this data via the Eulerpool API

Fuse Science Stock analysis

What does Fuse Science do? Fuse Science Inc. is a US-based company that focuses on the development and marketing of innovative technologies in the health and sports sector. The company was founded in 2008 and is headquartered in Miami Beach, Florida. History Fuse Science was founded by Brian Tuffin, who aimed to enhance the performance of athletes and fitness enthusiasts. In 2012, the company gained worldwide recognition by signing internationally renowned golfer Tiger Woods as its brand ambassador. This not only increased the company's visibility but also demonstrated its ability to attract stars in the sports world. Business model Fuse Science has an innovative business model for marketing and distributing its products. The company specializes in the production and marketing of products based on patented technologies. A crucial component of the business model is collaborating with well-known athletes and sports clubs. These ambassadors help portray the company's products as more consumer-friendly and credible. Another vital distribution channel is online commerce. Segments Fuse Science offers products in various segments: 1) Sports nutrition The sports nutrition segment includes a wide range of products, such as energy bars, gels, drinks, and supplements, aimed at improving athletes' performance and accelerating their post-workout recovery. 2) Pharmaceuticals Fuse Science also has a pharmaceutical segment focusing on the development of novel drugs. The company utilizes its patented technology to deliver medications faster into the body and enhance their effectiveness. An example of such a medication is Tegison, used in the treatment of severe skin conditions. 3) Cosmetics Fuse Science also offers a broad range of cosmetic products. These products aim to improve skin appearance and reduce wrinkles. Products Fuse Science has a variety of products on the market that rely on its patented technology. Some of the most well-known products include: 1) ElectroFuse ElectroFuse is an electrolyte drink that helps rehydrate the body after physical exertion. 2) PowerFuse PowerFuse is a dietary supplement aimed at improving athletes' performance and accelerating their post-workout recovery. 3) LipriSe LipriSe is a cream that helps reduce the appearance of wrinkles and age spots. Conclusion Fuse Science is an innovative company specializing in the development and marketing of products based on its patented technology. The company markets its products in both the sports and medical fields, aiming to enhance athletes' performance and improve people's overall health. Fuse Science has a promising future in developing new products that contribute to improving people's health and well-being. Fuse Science is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Fuse Science's Equity

Fuse Science's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Fuse Science's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Fuse Science's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Fuse Science's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Fuse Science’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Fuse Science stock

The Equity of Fuse Science is -11.22 M USD in 2026.

The Equity of Fuse Science changed from -2.18 M USD to -11.22 M USD, representing a 415.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Fuse Science since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Fuse Science historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Fuse Science

All Key Metrics — Fuse Science